SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-084141
Filing Date
2021-06-22
Accepted
2021-06-22 16:30:57
Documents
15
Period of Report
2021-06-17
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2120272d1_8k.htm   iXBRL 8-K 58610
2 EXHIBIT 3.1 tm2120272d1_ex3-1.htm EX-3.1 6961
3 EXHIBIT 10.1 tm2120272d1_ex10-1.htm EX-10.1 7957
4 EXHIBIT 10.2 tm2120272d1_ex10-2.htm EX-10.2 7817
  Complete submission text file 0001104659-21-084141.txt   266870

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mbio-20210617.xsd EX-101.SCH 3193
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20210617_lab.xml EX-101.LAB 34592
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20210617_pre.xml EX-101.PRE 22715
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2120272d1_8k_htm.xml XML 3713
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 211035707
SIC: 2834 Pharmaceutical Preparations